Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dementia With Lewy Bodies: early-phase trial registry
11 of 23 indexed Dementia With Lewy Bodies trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #724 of 28,707 conditions by registered trial count.
23 US clinical trials · 11 currently recruiting · #724 of 28,707 conditions by registered trial count
Dementia With Lewy Bodies: 23 US clinical trials tracked, 11 recruiting.
Dementia With Lewy Bodies is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Georgetown University, running 2 of these trials.
Enrollment posture brief
Registry condition dementia-with-lewy-bodies
OPEN 11 | RECR 48% | LATE 3 | EARLY 7 | RANK #724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Frontotemporal Dementia (48% recruiting · 23 trials)
Dementia With Lewy Bodies lists 11 open slots (48% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dementia With Lewy Bodies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dementia With Lewy Bodies is recruiting above its size-band peers.
11 of 23 indexed trials (47.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dementia With Lewy Bodies trials is spread across many organizations.
Georgetown University accounts for 2 of 23 trials (8.7%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Dementia With Lewy Bodies enrolment sits around 159 participants.
Median target enrolment is 159 among the 23 trials that report a genuine target (sentinel values excluded). 9 of those (39.1%) plan for fewer than 100 participants.
-
Dementia With Lewy Bodies splits between interventional and observational designs.
14 interventional and 9 observational studies make up this index (60.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
23 total, page 1 of 1
Modifiable Variables in Parkinsonism (MVP)
Bastyr University
NCT02194816
Natural History Study of Synucleinopathies
NYU Langone Health
NCT01799915
North American Prodromal Synucleinopathy Consortium Stage 2
Washington University School of Medicine
NCT05826457
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Virginia Commonwealth University
NCT07284290
Studies of Brain and Body Interaction
Rutgers University
NCT03672266
Comparing Antipsychotic Medications in LBD Over Time
The University of Texas Health Science Center at San Antonio
NCT05590637
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
Georgetown University
NCT04002674
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
University of Minnesota
NCT06467461
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Georgetown University
NCT03996460
PET Imaging Evaluation of [11C]SY08
Massachusetts General Hospital
NCT06098612
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Daniel Claassen
NCT04246437
Trial of Parkinson's And Zoledronic Acid
California Pacific Medical Center Research Institute
NCT03924414
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Ohio State University
NCT06357195
Community Outreach for Palliative Engagement -- Parkinson Disease
University of Rochester
NCT05222386
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Rush University Medical Center
NCT06389032
Environmental and Reproductive Health Risk for Lewy Body Dementia
University of California, San Diego
NCT06005935
Speech Accessibility Project
University of Illinois at Urbana-Champaign
NCT05889260
Synuclein-One Study
CND Life Sciences
NCT04700722
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
NCT06471660
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
EIP Pharma
NCT05869669
In-Home Care for Patients With PSP and Related Disorders
Rush University Medical Center
NCT03552484
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Avid Radiopharmaceuticals
NCT01503944
Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Columbia University
NCT02702102
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Dementia With Lewy Bodies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dementia With Lewy Bodies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dementia With Lewy Bodies page
23 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Dementia With Lewy Bodies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Georgetown University sponsors the most Dementia With Lewy Bodies trials on record, review their full trial history before evaluating a specific study. See Georgetown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia With Lewy Bodies condition card totals 23 registered trials; most-linked intervention Placebo; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.